Key result
This review evaluates different perioperative antiplatelet protocols in patients undergoing CABG to balance the risks of thrombotic events and perioperative bleeding.
Why the study?
What is the optimal perioperative antiplatelet protocol to balance thrombotic and bleeding risks in patients with coronary artery disease undergoing CABG?
Population
Patients with coronary artery disease undergoing coronary artery bypass grafting who are receiving one or…
Design
Review
Authors
Loading...
Antiplatelet management in CABG remains controversial; leaves open optimal perioperative strategy.
What is the optimal perioperative antiplatelet protocol to balance thrombotic and bleeding risks in patients with coronary artery disease undergoing CABG?
This review evaluates the controversial perioperative management of antiplatelet drugs in CABG patients, aiming to balance the competing risks of thrombosis and bleeding.
Ferrandis et al. (2009) conducted a review in Coronary artery disease. Perioperative antiplatelet protocols was evaluated. This review evaluates different perioperative antiplatelet protocols in patients undergoing CABG to balance the risks of thrombotic events and perioperative bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: